Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial-Reference-Cited by-同舟云学术

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial

Published:2019-10 Issue:7 Volume:8 Page:942-951
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Düngen Hans‐Dirk¹,Kober Lars²,Nodari Savina³,Schou Morten⁴,Otto Christiane⁵,Becka Michael⁶,Kanefendt Friederike⁷,Winkelmann Bernhard R.⁸,Gislason Gunnar⁹,Richard Frank¹⁰,Nielsen Olav Wendelboe¹¹,Gheorghiade Mihai¹²,Senni Michele¹³

Affiliation:

1. Department of Internal MedicineCardiologyCharité‐Universitaetsmedizin Berlin Germany

2. Department of CardiologyCopenhagen University Hospital Rigshospitalet Copenhagen Denmark

3. Cardiology SectionDepartment of Clinical and Surgical SpecialtiesRadiological Sciences and Public HealthUniversity of Brescia Brescia Italy

4. Department of CardiologyCardiovascular Research CenterGentofte and Herlev University Hospital Herlev Denmark

5. Experimental Medicine Cardiovascular and HematologyBAYER AG Wuppertal Germany

6. Research and Clinical Sciences StatisticsBAYER AG Wuppertal Germany

7. Clinical PharmacokineticsBAYER AG Wuppertal Germany

8. ClinPhenomics GmbH & Co KG Frankfurt Germany

9. Department of CardiologyCopenhagen University Hospital Herlev and Gentofte Copenhagen Denmark

10. Private Praxis for Cardiology Erfurt Germany

11. Department of CardiologyCopenhagen University Hospital Bispebjerg Copenhagen Denmark

12. Center for Cardiovascular InnovationNorthwestern University Feinberg School of Medicine Chicago IL USA

13. Division of Cardiology 1Papa Giovanni XXIII Hospital Bergamo Italy

Funder

BAYER AG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.633

Reference21 articles.

1. Acute Myocardial Infarction

2. Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure

3. Post-Myocardial Infarction Heart Failure

4. Left Ventricular Remodeling After Primary Coronary Angioplasty

5. Left Ventricular Remodeling in Heart Failure

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-(1-12): Does It Exist? A Critical Evaluation in Humans, Rats, and Mice;Hypertension;2024-08

2. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine;Cardiovascular Pathology;2024-07

3. Immunomodulation of Myocardial Fibrosis;JACC: Basic to Translational Science;2023-11

4. Update on Mast Cell Proteases as Drug Targets;Immunology and Allergy Clinics of North America;2023-11

5. Is chymase 1 a therapeutic target in cardiovascular disease?;Expert Opinion on Therapeutic Targets;2023-08-03